|
Mr. Liu Xiaohao is a Senior Vice President of the China Biopharmaceutical Holdings (CBH), in charge of sales operations. Mr. Liu has a strong track record and broad recognition in the drug industry in China. Prior to joining CBH, Mr. Liu held several senior marketing and sales management positions in some of the most powerful companies in the industry. For example, he served as the Vice General Manager of Shanghai Fuxin Pharmaceutical Corp. (" Fuxin "), the largest and among the most successful generic drug manufacturer in China, also listed on Shanghai Stock Exchange. Other prestigious sales management positions that Mr. Liu held were at companies such as: Nanjing Tian-Ying pharmaceutical Corp., Jiangsu Chang Ao Pharmaceutical Corp, Jiangsu Xuzhou Pharmaceutical Corp. Additionally, Mr. Liu organized seminars on various medicine and pharmaceutical topics including the first "National Forum on Narcotics and Intensive Care". Mr. Liu graduated from the SFDA Graduate Research Program in 2002 with M.S. degree in Pharmaceutical Administration and graduated from China Pharmaceutical University in 1986 with M.S. degree in Pharmacology. | 